StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.53−0.03 (-1.92%)

Close on Nov 17, 2026Market cap $2.00MP/E –Yield –

Can-Fite BioPharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$8.95M. The highest annual figure on record is -$4.16M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.95M–
FY2024Dec 31, 2024-$7.64M–
FY2023Dec 31, 2023-$8.44M–
FY2022Dec 31, 2022-$10.80M–
FY2021Dec 31, 2021-$9.86M–
FY2020Dec 31, 2020-$12.06M–
FY2019Dec 31, 2019-$11.08M–
FY2018Dec 31, 2018-$4.16M–
FY2017Dec 31, 2017-$8.97M–
FY2016Dec 31, 2016-$8.71M–
FY2015Dec 31, 2015-$4.82M–

More Can-Fite BioPharma figures

See a number that looks wrong?